ReleaseWire Connect

As per the new research report by RNCOS, “Emerging Indian NIPT Market”, a US$ 400 Million potential market for non-invasive prenatal testing (NIPT) market in India is brimming with opportunities and waiting to be explored. However, India is a price sensitive market. It would be very difficult for players to pitch a test with a price tag of more than US$ 1,000, which they would have to if they follow the global trend of flying the sample back to base laboratory. Such a model would, however favor BGI and Berry Genomics, who due to their geographical proximity, can enjoy lower freight charges.

US healthcare IT market is growing immensely due to declining costs of HIT systems’ implementation, stricter government regulations and huge incentives for implementation. Moreover, current industry trends such as emergence of cloud computing in healthcare IT, growing strategic collaborations and rapid technological upgradation in the industry are also playing pivotal roles in the development of country’s healthcare IT market. Considering the above factors, the US healthcare IT market is anticipated to grow at a CAGR of around 10% during 2014-2018.

Giant pharmaceutical players have increased their focused towards partnership agreements in a move to lower down the healthcare service expenditure. This will in a way support the effective and efficient development of biosimilars as well as provide players with first mover’s advantage in the market once the biologic’s patent get expired. Such pace of significant collaborations will not only strengthen companies to hold a dominant share in biosimilar market but will also expand their presence across nations. For instance, Baxter and Coherus Biosciences have entered into an exclusive partnership so as to develop and commercialize Etanercept for Europe, Brazil and Canada markets.

China has emerged as the most prominent and largest market for athletic footwear in Asia-Pacific region. The country is one of the largest athletic footwear manufacturing destinations with majority of the international footwear brands having their manufacturing facilities in China. Due to a large population base and rising concerns for fitness and healthy living, the athletic footwear demand in the country has risen. Our recent study reveals that the athletic footwear market is expected to grow at a CAGR of around 9.5% during 2013-2018 driven by growing disposable income, increasing athletic activities, unprecedented development of e-commerce and changing consumer preferences towards latest trends and fashions.

Indian Diagnostic Service Market has experienced a noticeable growth owing to increased healthcare spending, rising middle class income groups and expansion of commercial laboratories in Tier I and Tier II cities. Moreover, increasing awareness about the preventive healthcare offers ample opportunities for established players. Major diagnostic players have been expanding their footprint in cities and towns making the sector more organized. Market players have been expanding their services to rural regions via opening up sample collection centers and satellite laboratories. The whole of the hospital sector is undergoing consolidation therby boosting the overall performance of diagnostic services.

According to a new research report by RNCOS, “Saudi Arabia Steel Industry Outlook 2018”, the steel industry of Saudi Arabia is growing at a considerable rate over the past few years. The production and consumption of both semi-finished and finished steel is increasing in the country with the growth in infrastructure and manufacturing sectors amongst some. The rapid pace of industrialization has prompted the country to increase its steel production along with the reliance on imports. Moreover, with further development of infrastructure and commercial projects, the demand & production of steel is expected to increase in Kingdom in the coming years.

Countries such as India, China, Korea, Vietnam and Brazil are witnessing remarkable biosimilar uptake as compared to advanced economies. This surge can be attributed to local policies or the fragmented regulatory framework and “biosimilar” attitude of emerging nations. Within the concentrations of biopharmaceutical manufacturing globally, bio-clusters are emerging in the South Asian region, some of them matching the quality standards of advanced economies.

In US alone drugs worth US$ 67 Billion will lose patent protection by 2020. These patent expiries lined up until 2020 are proving to be the major driver for the biosimilar market. Most of these biologics belong to the category of mAbs and as evident from the pipeline, biosimilar manufacturers are eagerly waiting for them to lose their patents, so that biosimilars can cash in quickly.

As per the new research report by RNCOS, “Emerging Indian NIPT Market”, a US$ 400 Million potential market for non-invasive prenatal testing (NIPT) market in India is brimming with opportunities and waiting to be explored. In the report, various factors like the number of births by the age of mother, rural and urban split of such births; affordability factor for NIPT; and regulatory scenario have been prudently analysed to reflect a clear picture of the immense possibilities in the Indian NIPT market.

Used car market in India is expected to grow stupendously with small cars segment dominating the market. The growth in small used car segment is attributed to its high affordability, decent performance and high fuel economy. With its growing demand, small used car segment in India is anticipated to grow at a CAGR of around 15.7% during 2013-2017.